Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Milrinone
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Caplin Point Arm gets USFDA Nod for Milrinone Lactate in 5 pc Dextrose Injection
Details : Milrinone lactate is as a PDE3 inhibitor, which increases intracellular cyclic adenosine monophosphate levels in the heart and vascular muscle. It is indicated for acute decompensated heart failure.
Product Name : Primacor-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 03, 2025
Lead Product(s) : Milrinone
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Argatroban
Therapeutic Area : Hematology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Caplin Point Labs Gets USFDA Nod for Anticoagulant Injection
Details : Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Argatroban injection, 50 mg/50 ml (1 mg/ml), single-dose vial presentation, it said in a filing to BS...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 22, 2021
Lead Product(s) : Argatroban
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
